---
title: "Synergy CHC (SNYRQ) stock listing, news and investor profile"
url: "https://aibio.space/companies/synergy-chc/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Synergy CHC Corp. (OTC: SNYRQ), United States. Listing facts, related biotech companies and news on aibio.space."
---

SNYRQ Synergy CHC Corp. OTC · United States

# Synergy CHC (SNYRQ) news

Synergy CHC Corp. is a public biotech or pharmaceutical company listed on OTC under the ticker SNYRQ, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest Synergy CHC news

We have not published a story on Synergy CHC yet. When there is news, it will appear here.

## Synergy CHC at a glance

- **Ticker**: SNYRQ

- **Listing**: OTC

- **Country**: United States

- **Cash, Mar 31, 2026**: $292,115

### Related companies

- [HST Global](https://aibio.space/companies/hst-global/) OTC: HSTC
- [VITASPRING BIOMEDICAL CO. LTD.](https://aibio.space/companies/vitaspring-biomedical/) OTC: VSBC
- [Twist Bioscience](https://aibio.space/companies/twist-bioscience/) NASDAQ: TWST
- [CANNAPHARMARX, INC.](https://aibio.space/companies/cannapharmarx/) OTC: CPMD
- [Stereotaxis](https://aibio.space/companies/stereotaxis/) NYSE: STXS
- [Freenome](https://aibio.space/companies/freenome/) NASDAQ: FRNM
- [Jin Medical International](https://aibio.space/companies/jin-medical-international/) NASDAQ: ZJYL
- [Envista Holdings](https://aibio.space/companies/envista/) NYSE: NVST

### Also on OTC

- [Zomedica](https://aibio.space/companies/zomedica/) ZOMDF
- [OPTIGENEX INC](https://aibio.space/companies/optigenex/) OPGX
- [Altamira Therapeutics](https://aibio.space/companies/altamira-therapeutics/) CYTOF
- [Protagenic Therapeutics](https://aibio.space/companies/protagenic-therapeutics/) PTIX
- [Global Innovative Platforms](https://aibio.space/companies/global-innovative-platforms/) GIPL
- [ZENITH CAPITAL CORPORATION](https://aibio.space/companies/zenith-capital/) ZHCLF

## Synergy CHC annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | [$30.4 million](https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/) | [$34.8 million](https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/) |
| Net income (loss) | [-$12.3 million](https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/) | [$2.1 million](https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/) |
| Cash from operations | [-$2.6 million](https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/) | [-$4.8 million](https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/) |
| Cash and equivalents | [$2.6 million](https://www.sec.gov/Archives/edgar/data/1562733/000121390026056237/) | [$687,920](https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/) |

Latest balance sheet, Mar 31, 2026 (10-Q): cash and equivalents $292,115.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Synergy CHC

What is the ticker symbol of Synergy CHC?

Synergy CHC Corp. trades under the ticker SNYRQ on OTC.

Where is Synergy CHC listed?

Synergy CHC Corp. is listed on OTC.

Which country or territory is Synergy CHC listed under?

Our directory records Synergy CHC Corp. under United States.

Does aibio.space cover Synergy CHC?

aibio.space lists Synergy CHC Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Synergy CHC's revenue last year?

$30.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Synergy CHC profitable?

Synergy CHC Corp. reported a net loss of $12.3 million for the fiscal year ended Dec 31, 2025, and used $2.6 million of cash in operations, per its annual report to the SEC.

How much cash does Synergy CHC have?

$292,115 in cash at Mar 31, 2026, per its 10-Q.

## Investor discussion: Synergy CHC

Members talk about Synergy CHC (SNYRQ). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Synergy CHC, newest first. Each line links the filing it comes from.

1. 2026-09-16 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026100556/ea0305682-8k_synergy.htm)
2. 2026-09-08 Distress Reported a bankruptcy filing. SEC Form 8-K (Items 1.03,5.02). [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026097802/ea0304695-8k_synergy.htm)
3. 2026-08-26 Distress Reported that a debt obligation was accelerated. SEC Form 8-K (Items 2.04). [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026093728/ea0303430-8k_synergy.htm)
4. 2026-08-21 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026092335/ea030294401ex99-1.htm)
5. 2026-08-11 Distress Reported that a debt obligation was accelerated. SEC Form 8-K (Items 2.04). [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026087826/ea0301649-8k_synergy.htm)
6. 2026-06-29 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.02,5.07,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026073126/ea0296309-8k_synergy.htm)
7. 2026-05-18 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026058167/ea0291276-8k_synergy.htm)
8. 2026-04-30 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1562733/000121390026050246/ea0286780-04.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:SNYRQ on TradingView](https://www.tradingview.com/symbols/OTC-SNYRQ/).

## Listing details

Synergy CHC Corp. is a public biotech or pharmaceutical company listed on OTC under the ticker SNYRQ, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Synergy CHC Corp.

- **Ticker**: SNYRQ

- **Listing**: OTC

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/synergy-chc/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Synergy CHC (SNYRQ) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/synergy-chc/
